GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Natus Medical Inc (NAS:NTUS) » Definitions » ROA %

Natus Medical (Natus Medical) ROA % : 1.34% (As of Mar. 2022)


View and export this data going back to 2001. Start your Free Trial

What is Natus Medical ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Natus Medical's annualized Net Income for the quarter that ended in Mar. 2022 was $7.6 Mil. Natus Medical's average Total Assets over the quarter that ended in Mar. 2022 was $566.2 Mil. Therefore, Natus Medical's annualized ROA % for the quarter that ended in Mar. 2022 was 1.34%.

The historical rank and industry rank for Natus Medical's ROA % or its related term are showing as below:

NTUS's ROA % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -2.01
* Ranked among companies with meaningful ROA % only.

Natus Medical ROA % Historical Data

The historical data trend for Natus Medical's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Natus Medical ROA % Chart

Natus Medical Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.99 -3.40 -2.49 -2.72 2.26

Natus Medical Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.62 2.44 3.99 1.24 1.34

Competitive Comparison of Natus Medical's ROA %

For the Medical Devices subindustry, Natus Medical's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Natus Medical's ROA % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Natus Medical's ROA % distribution charts can be found below:

* The bar in red indicates where Natus Medical's ROA % falls into.



Natus Medical ROA % Calculation

Natus Medical's annualized ROA % for the fiscal year that ended in Dec. 2021 is calculated as:

ROA %=Net Income (A: Dec. 2021 )/( (Total Assets (A: Dec. 2020 )+Total Assets (A: Dec. 2021 ))/ count )
=13.177/( (600.394+564.288)/ 2 )
=13.177/582.341
=2.26 %

Natus Medical's annualized ROA % for the quarter that ended in Mar. 2022 is calculated as:

ROA %=Net Income (Q: Mar. 2022 )/( (Total Assets (Q: Dec. 2021 )+Total Assets (Q: Mar. 2022 ))/ count )
=7.612/( (564.288+568.083)/ 2 )
=7.612/566.1855
=1.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2022) net income data. ROA % is displayed in the 30-year financial page.


Natus Medical  (NAS:NTUS) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Mar. 2022 )
=Net Income/Total Assets
=7.612/566.1855
=(Net Income / Revenue)*(Revenue / Total Assets)
=(7.612 / 479.172)*(479.172 / 566.1855)
=Net Margin %*Asset Turnover
=1.59 %*0.8463
=1.34 %

Note: The Net Income data used here is four times the quarterly (Mar. 2022) net income data. The Revenue data used here is four times the quarterly (Mar. 2022) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Natus Medical ROA % Related Terms

Thank you for viewing the detailed overview of Natus Medical's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Natus Medical (Natus Medical) Business Description

Traded in Other Exchanges
N/A
Address
3150 Pleasant View Road, Middleton, WI, USA, 53562
Natus Medical Inc is a provider of newborn care, neurology, and hearing and balance assessment healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. It is divided into three business units: Neuro, Newborn Care, and Hearing and Balance. The company generates a majority of its revenue from the Neurology business unit which includes products and services that provide diagnostic, therapeutic and surgical solutions in neurodiagnostics, neurocritical care, and neurosurgery.
Executives
Chung Dong Chune Christopher officer: Vice President Medical Affairs 1501 INDUSTRIAL ROAD SAN CARLOS CA 94070
Bryant M Moore director 181 HARVEST LANE PITTSBORO NC 27312
Eric Guerin director 1950 HASSELL ROAD, HOFFMAN ESTATES IL 60169
Ilan Daskal director 1000 ALFRED NOBEL DRIVE, HERCULES CA 94547
Alice D. Schroeder director 1573 MALLORY LANE, SUITE 100, BRENTWOOD TN 37027
Lisa Wipperman Heine director 1244 76TH STREET WEST, INVER GROVE HEIGHTS MN 55077
Jonathan Kennedy director, officer: Sr. VP, CFO INTERSIL CORPORATION, 1001 MURPHY RANCH ROAD, MILPITAS CA 95035
Ken Ludlum director
Robert A Gunst director
Noll Austin Francis Iii officer: VP/GM Neurology 9805 FALLEN LEAF DRIVE MIDDLETON WI 53562
Thomas Joseph Sullivan director 64 PETTIT PL PRINCETON NJ 08540
Benjamin Drew Davies officer: Sr. VP, CFO 1501 INDUSTRIAL ROAD, SAN CARLOS X1 94070
Joshua Levine director 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
Sharon Villaverde officer: Interim CFO 11780 U.S. HIGHWAY 1, SUITE 600, PALM BEACH GARDENS FL 33408
William M Moore director